The mismatch runs along three axes at once: formulation (DAC versus no-DAC for CJC-1295), route (intravenous versus subcutaneous for Ipamorelin), and endpoint (GH/IGF-I pharmacodynamics or gastrointestinal recovery, versus GH-pulse modeling)
The options may be chosen on the product page Tesamorelin Nasal Spray Price range: $47.22 through $87.75 This product has multiple variants
Ocular complications from glucagon-like peptide-1 receptor agonists: Clinical evidence, potential mechanisms, and clinical recommendations
The receptor itself couples to multiple G proteins (Gq/11, Gi/o, G12/13, and -arrestin), and different agonists can bias signaling toward different pathways (Overlapping binding site study, 2008)
However, there is no scientific evidence to support its effectiveness as a topical agent
Never exceed 100 mcg/day in research settings higher doses show diminishing returns